{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:23:20Z","timestamp":1793737400864,"version":"4.6.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol Exp"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Total body weight (TBW) is a frequently used contrast media (CM) strategy for dose calculation in enhanced CT, yet it is suboptimal as it lacks consideration of patient characteristics, such as body fat percentage (BFP) and muscle mass. Alternative CM dosage strategies are suggested by the literature. Our objectives were to analyze the CM dose impact when adjusting to body composition using methods of obtaining lean body mass (LBM) and body surface area (BSA) along with its correlation with demographic factors in contrast enhanced chest CT examinations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Eighty-nine adult patients referred for CM thoracic CT were retrospectively included, categorized as either normal, muscular, or overweight. Patient body composition data was used to calculate the CM dose according to LBM or BSA. LBM was calculated with the James method, Boer method, and bioelectric impedance (BIA). BSA was calculated using the Mostellar formula. We then correlated the corresponding CM doses with demographic factors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>BIA demonstrated the highest and lowest calculated CM dose in muscular and overweight groups respectively, compared to other strategies. For the normal group, the lowest calculated CM dose was achieved using TBW. The calculated CM dose was more closely correlated with BFP using the BIA method.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The BIA method is more adaptive to variations in patient body habitus especially in muscular and overweight patients and is most closely correlated to patient demographics. This study could support utilizing the BIA method for calculating LBM for a body-tailored CM dose protocol for enhanced chest CT examinations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Relevance statement<\/jats:title>\n                <jats:p>The BIA-based method is adaptive to variations in body habitus especially in muscular and overweight patients and is closely correlated to patient demographics for contrast-enhanced chest CT.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Key points<\/jats:title>\n                <jats:p>\u2022 Calculations based on BIA showed the largest variation in CM dose.<\/jats:p>\n                <jats:p>\u2022 Lean body weight using BIA demonstrated the strongest correlation to patient demographics.<\/jats:p>\n                <jats:p>\u2022 Lean body weight BIA protocol may be considered for CM dosing in chest CT.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s41747-023-00345-w","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:01:54Z","timestamp":1686528114000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Strategies for calculating contrast media dose for chest CT"],"prefix":"10.1186","volume":"7","author":[{"given":"Mette Karen","family":"Henning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Gunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Arenas-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2307-4179","authenticated-orcid":false,"given":"Safora","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,12]]},"reference":[{"key":"345_CR1","doi-asserted-by":"publisher","first-page":"108630","DOI":"10.1016\/j.ejrad.2019.07.031","volume":"121","author":"MS Walgraeve","year":"2019","unstructured":"Walgraeve MS, Pyfferoen L, Van De Moortele K, Zanca F, Bielen D, Casselman JW (2019) Implementation of patient-tailored contrast volumes based on body surface area and heart rate harmonizes contrast enhancement and reduces contrast load in small patients in portal venous phase abdominal CT. Eur J Radiol 121:108630. https:\/\/doi.org\/10.1016\/j.ejrad.2019.07.031","journal-title":"Eur J Radiol"},{"key":"345_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41747-017-0006-5","volume":"1","author":"F Sardanelli","year":"2017","unstructured":"Sardanelli F (2017) Trends in radiology and experimental research. Eur Radiol Exp 1:1. https:\/\/doi.org\/10.1186\/s41747-017-0006-5","journal-title":"Eur Radiol Exp"},{"key":"345_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1148\/radiol.10090908","volume":"256","author":"KT Bae","year":"2010","unstructured":"Bae KT (2010) Intravenous contrast medium administration and scan timing at CT: considerations and approaches. Radiology 256:32\u201361. https:\/\/doi.org\/10.1148\/radiol.10090908","journal-title":"Radiology"},{"key":"345_CR4","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1258\/ar.2012.120268","volume":"53","author":"A Svensson","year":"2012","unstructured":"Svensson A, Nouhad J, Cederlund K et al (2012) Hepatic contrast medium enhancement at computed tomography and its correlation with various body size measures. Acta Radiol 53:601\u2013606. https:\/\/doi.org\/10.1258\/ar.2012.120268","journal-title":"Acta Radiol"},{"key":"345_CR5","doi-asserted-by":"publisher","first-page":"5407936","DOI":"10.1155\/2020\/5407936","volume":"2020","author":"NG Eijsvoogel","year":"2020","unstructured":"Eijsvoogel NG, Hendriks BMF, Nelemans P et al (2020) Personalization of CM injection protocols in coronary Computed Tomographic Angiography (People CT Trial). Contrast Media Mol Imaging 2020:5407936. https:\/\/doi.org\/10.1155\/2020\/5407936","journal-title":"Contrast Media Mol Imaging"},{"key":"345_CR6","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1007\/s00261-017-1156-x","volume":"42","author":"M Rengo","year":"2017","unstructured":"Rengo M, Bellini D, Businaro R et al (2017) MDCT of the liver in obese patients: evaluation of a different method to optimize iodine dose. Abdom Radiol (NY) 42:2420\u20132427. https:\/\/doi.org\/10.1007\/s00261-017-1156-x","journal-title":"Abdom Radiol (NY)"},{"key":"345_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s41747-018-0074-1","volume":"2","author":"M Zanardo","year":"2018","unstructured":"Zanardo M, Doniselli FM, Esseridou A et al (2018) Abdominal CT: a radiologist-driven adjustment of the dose of iodinated contrast agent approaches a calculation per lean body weight. Eur Radiol Exp 2:41. https:\/\/doi.org\/10.1186\/s41747-018-0074-1","journal-title":"Eur Radiol Exp"},{"key":"345_CR8","doi-asserted-by":"publisher","first-page":"777","DOI":"10.2214\/ajr.07.2765","volume":"190","author":"KT Bae","year":"2008","unstructured":"Bae KT, Seeck BA, Hildebolt CF et al (2008) Contrast enhancement in cardiovascular MDCT: effect of body weight, height, body surface area, body mass index, and obesity. AJR Am J Roentgenol 190:777\u2013784. https:\/\/doi.org\/10.2214\/ajr.07.2765","journal-title":"AJR Am J Roentgenol"},{"key":"345_CR9","doi-asserted-by":"publisher","first-page":"109778","DOI":"10.1016\/j.ejrad.2021.109778","volume":"141","author":"E Janek","year":"2021","unstructured":"Janek E, Edl D, Taflinski A et al (2021) Contrast media dose adjustment to allometric parameters of body mass in multiphasic CT of the liver: a comparison of different metrics. Eur J Radiol 141:109778. https:\/\/doi.org\/10.1016\/j.ejrad.2021.109778","journal-title":"Eur J Radiol"},{"issue":"5","key":"345_CR10","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1590\/s1806-37562017000000179","volume":"43","author":"B Hochhegger","year":"2017","unstructured":"Hochhegger B, Rottenfusser R, Marchiori E (2017) When is the use of contrast media in chest CT indicated? J Bras Pneumol 43(5):400. https:\/\/doi.org\/10.1590\/s1806-37562017000000179","journal-title":"J Bras Pneumol"},{"key":"345_CR11","doi-asserted-by":"publisher","first-page":"8521893","DOI":"10.1155\/2018\/8521893","volume":"2018","author":"D Caruso","year":"2018","unstructured":"Caruso D, De Santis D, Rivosecchi F et al (2018) Lean body weight-tailored iodinated contrast injection in obese patient: Boer versus James formula. Biomed Res Int 2018:8521893. https:\/\/doi.org\/10.1155\/2018\/8521893","journal-title":"Biomed Res Int"},{"key":"345_CR12","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/med.0000000000000360","volume":"24","author":"T Lemos","year":"2017","unstructured":"Lemos T, Gallagher D (2017) Current body composition measurement techniques. Curr Opin Endocrinol Diabetes Obes 24:310\u2013314. https:\/\/doi.org\/10.1097\/med.0000000000000360","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"345_CR13","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1200\/jgo.2016.005876","volume":"2","author":"W Faisal","year":"2016","unstructured":"Faisal W, Tang HM, Tiley S, Kukard C (2016) Not all body surface area formulas are the same, but does it matter? J Glob Oncol 2:436\u2013437. https:\/\/doi.org\/10.1200\/jgo.2016.005876","journal-title":"J Glob Oncol"},{"key":"345_CR14","unstructured":"U.S. Food and Drug Administration. FDA Drug Shortages. https:\/\/www.accessdata.fda.gov\/scripts\/drugshortages\/default.cfm. Accessed 20 Feb 2023."},{"key":"345_CR15","doi-asserted-by":"publisher","first-page":"666","DOI":"10.2214\/ajr.22.27969","volume":"219","author":"JJ Cavallo","year":"2022","unstructured":"Cavallo JJ, Pahade JK (2022) Practice management strategies for imaging facilities facing an acute iodinated contrast media shortage. AJR Am J Roentgenol 219:666\u2013670. https:\/\/doi.org\/10.2214\/ajr.22.27969","journal-title":"AJR Am J Roentgenol"},{"key":"345_CR16","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s10140-022-02077-7","volume":"29","author":"LS Eibschutz","year":"2022","unstructured":"Eibschutz LS, Gholamrezanezhad A (2022) How low can we go? Strategies and recommendations to combat the iodinated contrast shortage. Emerg Radiol 29:925\u2013928. https:\/\/doi.org\/10.1007\/s10140-022-02077-7","journal-title":"Emerg Radiol"},{"key":"345_CR17","doi-asserted-by":"publisher","first-page":"974","DOI":"10.2214\/ajr.22.28060","volume":"219","author":"IL Barreto","year":"2022","unstructured":"Barreto IL, Grajo JR, Brock DE, Magnelli L, Patel P, Hochhegger B (2022) A health system\u2019s response to the ongoing global shortage of iodinated contrast media. AJR Am J Roentgenol 219:974\u2013979. https:\/\/doi.org\/10.2214\/ajr.22.28060","journal-title":"AJR Am J Roentgenol"},{"key":"345_CR18","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1148\/radiology.216.3.r00se26718","volume":"216","author":"Y Yamashita","year":"2000","unstructured":"Yamashita Y, Komohara Y, Takahashi M et al (2000) Abdominal helical CT: evaluation of optimal doses of intravenous contrast material\u2013a prospective randomized study. Radiology 216:718\u2013723. https:\/\/doi.org\/10.1148\/radiology.216.3.r00se26718","journal-title":"Radiology"},{"key":"345_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.radi.2020.07.012","volume":"27","author":"K Dastan","year":"2021","unstructured":"Dastan K, Henning MK, England A, Aalokken TM, Johansen S (2021) An investigation into the variability of radiographers assessing body composition prior to CT contrast media administration. Radiography (Lond) 27:168\u2013172. https:\/\/doi.org\/10.1016\/j.radi.2020.07.012","journal-title":"Radiography (Lond)"},{"key":"345_CR20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/RCT.0b013e31827dbc08","volume":"37","author":"M Kidoh","year":"2013","unstructured":"Kidoh M, Nakaura T, Oda S et al (2013) Contrast enhancement during hepatic computed tomography: effect of total body weight, height, body mass index, blood volume, lean body weight, and body surface area. J Comput Assist Tomogr 37:159\u2013164. https:\/\/doi.org\/10.1097\/RCT.0b013e31827dbc08","journal-title":"J Comput Assist Tomogr"},{"key":"345_CR21","doi-asserted-by":"publisher","unstructured":"Henning MK, Aal\u00f8kken TM, Johansen S (2021) Contrast medium protocols in routine chest CT: a survey study. Acta Radiol 284185121997111 https:\/\/doi.org\/10.1177\/0284185121997111","DOI":"10.1177\/0284185121997111"},{"key":"345_CR22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13244-020-00920-4","volume":"11","author":"M Zanardo","year":"2020","unstructured":"Zanardo M, Doniselli FM, Esseridou A et al (2020) Lean body weight versus total body weight to calculate the iodinated contrast media volume in abdominal CT: a randomised controlled trial. Insights Imaging 11:132. https:\/\/doi.org\/10.1186\/s13244-020-00920-4","journal-title":"Insights Imaging"},{"key":"345_CR23","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1148\/radiol.2016152031","volume":"278","author":"U Nyman","year":"2016","unstructured":"Nyman U (2016) James lean body weight formula is not appropriate for determining CT contrast media dose in patients with high body mass index. Radiology 278:956\u2013957. https:\/\/doi.org\/10.1148\/radiol.2016152031","journal-title":"Radiology"},{"key":"345_CR24","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.oraloncology.2016.08.012","volume":"61","author":"S Chamchod","year":"2016","unstructured":"Chamchod S, Fuller CD, Mohamed AS et al (2016) Quantitative body mass characterization before and after head and neck cancer radiotherapy: a challenge of height-weight formulae using computed tomography measurement. Oral Oncol 61:62\u201369. https:\/\/doi.org\/10.1016\/j.oraloncology.2016.08.012","journal-title":"Oral Oncol"},{"key":"345_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/ajcn\/47.1.7","volume":"47","author":"KR Segal","year":"1988","unstructured":"Segal KR, Van Loan M, Fitzgerald PI, Hodgdon JA, Van Itallie TB (1988) Lean body mass estimation by bioelectrical impedance analysis: a four-site cross-validation study. Am J Clin Nutr 47:7\u201314. https:\/\/doi.org\/10.1093\/ajcn\/47.1.7","journal-title":"Am J Clin Nutr"},{"key":"345_CR26","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41430-018-0335-3","volume":"73","author":"LC Ward","year":"2019","unstructured":"Ward LC (2019) Bioelectrical impedance analysis for body composition assessment: reflections on accuracy, clinical utility, and standardisation. Eur J Clin Nutr 73:194\u2013199. https:\/\/doi.org\/10.1038\/s41430-018-0335-3","journal-title":"Eur J Clin Nutr"},{"key":"345_CR27","doi-asserted-by":"publisher","first-page":"3548284","DOI":"10.1155\/2019\/3548284","volume":"2019","author":"M Marra","year":"2019","unstructured":"Marra M, Sammarco R, De Lorenzo A et al (2019) Assessment of body composition in health and disease using Bioelectrical Impedance Analysis (BIA) and Dual Energy x-ray Absorptiometry (DXA): a critical overview. Contrast Media Mol Imaging 2019:3548284. https:\/\/doi.org\/10.1155\/2019\/3548284","journal-title":"Contrast Media Mol Imaging"}],"container-title":["European Radiology Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41747-023-00345-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41747-023-00345-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41747-023-00345-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T15:10:29Z","timestamp":1689001829000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurradiolexp.springeropen.com\/articles\/10.1186\/s41747-023-00345-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,12]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["345"],"URL":"https:\/\/doi.org\/10.1186\/s41747-023-00345-w","relation":{},"ISSN":["2509-9280"],"issn-type":[{"value":"2509-9280","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,12]]},"assertion":[{"value":"22 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study utilized a patient dataset collected during the period of 2019\u20132021 at Oslo University Hospital. The study was approved by the Norwegian Regional Medical Research Ethics Committee (No. 2016\/674) and Data Protection Officer at the institution. Informed consent was waived from patients. Trial registration: ClinicalTrials.gov, Identifier no. NCT05645796, registered on the 9th December 2022.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}